Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus

标题
Biomarker Signatures Correlate with Clinical Outcome in Refractory Metastatic Colorectal Cancer Patients Receiving Bevacizumab and Everolimus
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 4, Pages 1048-1056
出版商
American Association for Cancer Research (AACR)
发表日期
2015-02-20
DOI
10.1158/1535-7163.mct-14-0923-t

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search